BMRN
NASDAQStockBioMarin Pharmaceutical Inc.
$59.51-0.78 (-1.29%)
52-Week Range
$51.46
$72.83
Key Stats
Market Cap
11.4B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.26
Volume
1.2M
Avg Volume
2.3M
Performance
1M
-2.06%
3M
+13.33%
6M
+11.16%
YTD
-0.64%
1Y
-16.33%
3Y
-34.55%
5Y
-24.65%
Price Chart
ETF Exposure
BMRN is held by 187 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GNOM | Global X - Genomics & Biotechnology ETF | 4.49% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.69% |
| PBE | Invesco Biotechnology & Genome ETF | 2.78% |
| INVN | Alger Russell Innovation ETF | 2.14% |
| BBP | Virtus Biotech ETF | 1.75% |
| DBLV | AdvisorShares DoubleLine Value Equity ETF | 1.42% |
| FXH | First Trust Health Care AlphaDEX Fund | 1.41% |
| XBI | State Street SPDR S&P Biotech ETF | 1.38% |
| QQQN | VictoryShares Nasdaq Next 50 ETF | 1.29% |
| BBH | VanEck Biotech ETF | 1.23% |
| BMED | iShares Health Innovation Active ETF | 1.21% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 1.20% |
| IQSM | NYLI Candriam U.S. Mid Cap Equity ETF | 1.07% |
| WDNA | WisdomTree BioRevolution Fund | 1.06% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 1.04% |
| SFLO | VictoryShares Small Cap Free Cash Flow ETF | 1.03% |
| IBB | iShares Biotechnology ETF | 1.00% |
| CTRU | ARK Transparency ETF | 0.97% |
| MRND | IQ U.S. Mid Cap R&D Leaders ETF | 0.90% |
| CALF | Pacer US Small Cap Cash Cows ETF | 0.90% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.89% |
| SMOT | VanEck Morningstar SMID Moat ETF | 0.78% |
| XHYH | BondBloxx USD High Yield Bond Healthcare Sector ETF | 0.76% |
| FLOW | Global X - U.S. Cash Flow Kings 100 ETF | 0.76% |
| COWG | Pacer US Large Cap Cash Cows Growth Leaders ETF | 0.68% |
| SMMV | iShares MSCI USA Small-Cap Min Vol Factor ETF | 0.64% |
| LCF | Touchstone US Large Cap Focused ETF | 0.61% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.60% |
| SMOX | Horizon Small/Mid Cap Core Equity ETF | 0.60% |
| MIDE | Xtrackers S&P MidCap 400 Scored & Screened ETF | 0.56% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.48% |
| AFMC | First Trust Active Factor Mid Cap ETF | 0.45% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.45% |
| QVMM | Invesco S&P MidCap 400 QVM Multi-factor ETF | 0.41% |
| XJH | iShares ESG Select Screened S&P Mid-Cap ETF | 0.41% |
| RBUS | Nationwide Risk-Based U.S. Equity ETF | 0.40% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 0.38% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 0.38% |
| USMF | WisdomTree U.S. Multifactor Fund | 0.36% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 0.36% |
| SPMD | State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.35% |
| IJH | iShares Core S&P Mid-Cap ETF | 0.35% |
| MDY | State Street SPDR S&P MIDCAP 400 ETF Trust | 0.35% |
| DWSH | AdvisorShares Dorsey Wright Short ETF | 0.35% |
| DFAS | Dimensional - US Small Cap ETF | 0.34% |
| VBK | Vanguard Small-Cap Growth ETF | 0.34% |
| IVOO | Vanguard S&P Mid-Cap 400 ETF | 0.32% |
| MDYV | State Street SPDR S&P 400 Mid Cap Value ETF | 0.32% |
| IJJ | iShares S&P Mid-Cap 400 Value ETF | 0.32% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 0.32% |
Page 1 of 4Next
About BMRN ETF Exposure
BioMarin Pharmaceutical Inc. (BMRN) is held by 187 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 11.4B, BMRN is a widely held institutional stock. The stock currently trades at $59.51. Investors can gain exposure to BMRN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BMRN, sorted by portfolio weight.